Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.

Lee, Dong Heon; Park, So Yun; Hong, Narang; Kook, Hyung Don; Jung, Hye Jung; Park, Mi Youn; Ahn, Jiyoung

Lee, Dong Heon; Park, So Yun; Hong, Narang; Kook, Hyung Don; Jung, Hye Jung; Park, Mi Youn; Ahn, Jiyoung.

Afiliação

Lee DH; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Park SY; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Hong N; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Kook HD; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Jung HJ; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Park MY; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.
Ahn J; Department of Dermatology, National Medical Center, Seoul, Republic of Korea.

Dermatol Ther ; 35(11): e15802, 2022 11.

Article em En | MEDLINE | ID: mdl-36043599

Assuntos

Azetidinas; Dermatite Atópica; Humanos; Dermatite Atópica/diagnóstico; Dermatite Atópica/tratamento farmacológico; Anticorpos Monoclonais Humanizados; Azetidinas/uso terapêutico; Resultado do Tratamento; Índice de Gravidade de Doença

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azetidinas / Dermatite Atópica Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Dermatol Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google